Premier Alternatives

Alloy (Pharmaceuticals)

New York, NY · Founded 2019 · Privately Held (backing)

Developer of women's health care products intended to promote wellness and manage menopause effectively. Alloy (Pharmaceuticals) is based in New York, NY and was founded in 2019. Its last known valuation is $160 million. It has raised $18.3 million.

Last price · $/share
—
Implied valuation
$160.0M
Total raised
$18.3M
Last round
—
What is Alloy (Pharmaceuticals) worth?
$160.0Mlast known valuation
Free account
More of Alloy (Pharmaceuticals) with a free account
  • ·Watch Alloy (Pharmaceuticals): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Alloy (Pharmaceuticals) funding history

No rounds on record

No funding rounds for Alloy (Pharmaceuticals) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Alloy (Pharmaceuticals) valuation

Alloy (Pharmaceuticals)'s last known valuation is $160 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Alloy (Pharmaceuticals)'s valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Alloy (Pharmaceuticals), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Alloy (Pharmaceuticals)

What is Alloy (Pharmaceuticals) worth?
Alloy (Pharmaceuticals)'s last known valuation is $160.0M.
How much has Alloy (Pharmaceuticals) raised?
Alloy (Pharmaceuticals) has raised $18.3M in total funding across its recorded rounds.